↓ Skip to main content

Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension.

Overview of attention for article published in JAMA Internal Medicine, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
222 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension.
Published in
JAMA Internal Medicine, December 2018
DOI 10.1001/jamainternmed.2018.4684
Pubmed ID
Authors

James P Sheppard, Sarah Stevens, Richard Stevens, Una Martin, Jonathan Mant, F D Richard Hobbs, Richard J McManus

X Demographics

X Demographics

The data shown below were collected from the profiles of 743 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 222 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 222 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 30 14%
Other 28 13%
Student > Ph. D. Student 24 11%
Student > Bachelor 20 9%
Student > Master 17 8%
Other 54 24%
Unknown 49 22%
Readers by discipline Count As %
Medicine and Dentistry 103 46%
Nursing and Health Professions 11 5%
Pharmacology, Toxicology and Pharmaceutical Science 11 5%
Agricultural and Biological Sciences 4 2%
Biochemistry, Genetics and Molecular Biology 4 2%
Other 20 9%
Unknown 69 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 593. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2023.
All research outputs
#39,160
of 25,587,485 outputs
Outputs from JAMA Internal Medicine
#352
of 11,677 outputs
Outputs of similar age
#724
of 447,102 outputs
Outputs of similar age from JAMA Internal Medicine
#11
of 125 outputs
Altmetric has tracked 25,587,485 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,677 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 85.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,102 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.